Results 101 to 110 of about 8,431 (215)

KRAS and GNAS mutations in cell‐free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study

open access: yesMolecular Oncology
Intraductal papillary mucinous neoplasms (IPMNs) are potential precursor lesions of pancreatic cancer. We assessed the efficacy of screening for KRAS proto‐oncogene, GTPase (KRAS), and GNAS complex locus (GNAS) mutations in cell‐free DNA (cfDNA)—using ...
Christine Nitschke   +12 more
doaj   +1 more source

Adjuvant therapy (Adj) in intraductal papillary mucinous neoplasm cancer (IPMN-Ca) versus pancreatic ductal adenocarcinoma (PDAC): Comparison of survival analyses.

open access: yes, 2015
385 Background: Incidence of IPMN-Ca is increasing and due to lack of large prospective trials to evaluate optimal management of IPMN-Ca following resection, benefit of Adj is unknown.
Darwin Conwell   +6 more
core   +1 more source

Molecular and clinical patterns of local progression in the pancreatic remnant following resection of pancreatic intraductal papillary mucinous neoplasm (IPMN)

open access: yes, 2019
Intraductal papillary mucinous neoplasms (IPMN) are pancreatic cystic lesions that can progress to invasive carcinoma. Consensus guidelines indicate surgery for IPMN at high risk of malignant progression, as assessed by specific radiological and clinical
Salvia, Roberto   +3 more
core   +1 more source

Iatrogenic pancreatitis in patients with IPMN after ERCP: incidence and predictive signs.

open access: yes, 2014
BACKGROUND AND AIMS: The prevalence of intraductal papillary mucinous neoplasm (IPMN) has recently increased, and endoscopic retrograde cholangiopancreatography (ERCP) is a major diagnostic modality for IPMN. The aim of our study was to determine the
Cho, CM   +7 more
core   +1 more source

Single-operator pancreatoscopy is helpful in the evaluation of suspected intraductal papillary mucinous neoplasms (IPMN)

open access: yes, 2014
BACKGROUND AND OBJECTIVE: Even when advanced cross-sectional imaging modalities have been employed, endoscopic evaluation of intraductal papillary mucinous neoplasms (IPMN) is often required in order to assess the final character and extent of lesions ...
Arnelo, Urban   +8 more
core   +1 more source

Subtype‐associated complexity and prognostic significance of the NLRP3 inflammasome landscape in pancreatic neoplasms

open access: yesThe Journal of Pathology: Clinical Research
Intraductal papillary mucinous neoplasm (IPMN) can progress into malignant pancreatic cancer, posing challenges in accurately assessing the risk of malignancy.
Kristóf Németh   +7 more
doaj   +1 more source

Trattamento chirurgico delle IPMN del pancreas

open access: yes
L’incidenza delle IPMN pancreatiche è cospicuamente aumentata negli ultimi 10 anni, nonostante la gestione di questo tipo di patologia rimanga per molti aspetti ancora controversa.
GENNAI, ANDREA
core  

A pancreas praecancerosisai: intraepithelialis neoplasia (PanIN) és intraductalis papillaris mucinosus neoplasia (IPMN)

open access: yes, 2015
Pancreatic Intraepithelial Neoplasia (PanIN1-3) and Intraductal Papillary Mucinous Neoplasms (IPMN) putative precursors of and associated to pancreatic cancer represent a distinct, however pathologically heterogenous entity. Recently a new classification
Bognár, Gábor   +4 more
core   +1 more source

[Carcinogenesis of IPMN].

open access: yesNihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2012
TADA, Minoru, KOIKE, Kazuhiko
openaire   +2 more sources

中国人胰腺导管内乳头状粘液性肿瘤B-RAF基因(V600E)突变的研究

open access: yesZhongguo shiyan zhenduanxue, 2015
胰腺导管内乳头状粘液性肿瘤(Intraductal Papillary Mucinous Neoplasms of the Pancreas,IPMNs)是胰腺癌最重要及最常见的癌前病变之一,约占临床诊断胰腺肿瘤的7%,占偶然发现的胰腺囊肿的50%[1,2]。IPMN分型包括伴轻度不典型增生、IPMN伴中度不典型增生、IPMN伴重度不典型增生及IPMN相关浸润性 ...
张晓鸽, 赵建军, 王庆宇, 杨蕾
doaj  

Home - About - Disclaimer - Privacy